Surgeon In Chief @UCSFCancer | Professor and Chief of Surgical Oncology @UCSFSurgery | tumor immunologist | Passionate about CRLM and IPMN | Loving Dad
- Tweets 257
- Following 36
- Followers 1,349
- Likes 855
Ajay Maker retweeted
New in @JournalofGISurg: How have IAP guidelines changed how we select IPMNs for surgery?🔪
Across 3 guideline eras, resected noninvasive cysts got bigger ⬆️(2.6>3cm) while invasive ones got smaller ⬇️(3.1>2.8cm) @Maker_MD @UCSFSurgery @BrighamSurgery
sciencedirect.com/science/au…
1
2
3
225
Congratulations Dr. Esserman! @UCSFSurgery #UCSFSurgOnc
The AIM-HI Accelerator Fund is pleased to announce Laura Esserman, M.D., MBA, Director of the University of California, San Francisco (UCSF) Breast Care Center, as the recipient of the 2026 AIM-HI Beacon Award for Women Leaders in Oncology. Congratulations, Dr. Esserman! 🎉
2
346
Honored & 🙏🏽 to receive the SSO Scholarship to the SUS Leadership Agility Program at @KelloggSchool of Management. Truly 🔥 executive leadership course with 💪🏽 faculty and colleagues from across academic surgery. Grateful to all who made this possible. @SocSurgOnc @UnivSurg
2
3
23
1,961
Ajay Maker retweeted
Want to learn about options and decision-making for colorectal liver metastases?
Check out this paper from SSAT-SSO joint symposium at #DDW2026
including biology-guided systemic therapy, ctDNA, parenchymal preservation, ablation, transplant
📝 doi.org/10.1016/j.gassur.202…
Made with AI
1
9
26
1,541
Ajay Maker retweeted
Check out our new paper on increased utilization of ITx in uveal melanoma liver metastases
Unlike cutaneous melanoma, use of ITx was NOT associated with improved survival. More liver directed therapies are needed 🔜
@Maker_MD @UCSFSurgery @BrighamSurgery
authors.elsevier.com/a/1nIEN…
1
2
2
186
Deeply honored to be the Don Morton Visiting Professor and deliver his lectureship at @wvu_surgery. I hope we kept his discoveries alive discussing metastasectomy & immunotherapy. Incredibly impressed w/WVU 🔪 & 🔬 Grateful for incredible hospitality! @UCSFSurgery @UCSFHospitals
3
19
1,378
A couple of times each 📆, I enjoy dinner with our clinical asst. professors. Always great to discuss clinical/research updates, share ideas and practices, & learn from one another. Grateful for their new ideas, programs, and energy moving #UCSFSurgOnc forward!
2
3
19
1,867
Truly an honor to receive the @AmerSurg-European Surgical Association Exchange Award in Rome last week. 🙏🏽 to the leaders of both societies and gracious hosts at San Raffaele and Humanitas! 🇮🇹@Massimo04868945 @TorzilliGuido @StefanoCrippa6 @spartelli @lelecapurso #ESA2026
ALT Honored to receive this award with @gru6n and honorary member @jdimick1
1
3
19
1,151
Ajay Maker retweeted
The liver isn’t just passive “soil” for cancer spread – it’s an active partner. Understanding its immune-tolerant environment could unlock new therapies for colorectal cancer metastases, says @Maker_MD of @UCSFCancer and @UCSFSurgery. #Oncology #DDW2026 #LiverTwitter
2
4
11
1,337
Ajay Maker retweeted
The Tissue is the Tissue at #AHPBA2026 @Maker_MD gave a fantastic talk on some of the innovative ways we are taking on the biology of cancer @UCSFSurgery and @UCSFCancer! Using our own immune system to fight against cancer is how we will get the job done 🧪
4
21
1,509
👏🏼👏🏼👏🏼Congratulations to our many #UCSFSurgOnc trainees, fellows, and faculty for their outstanding contributions and presentations at #AHPBA2026 ! @UCSFSurgery @mohamedadamMD @HPB_Surgeon @SEHernandezz @LThornblade @stasinosmd @UCSFGSResidency @Lalehforoutani @paul_wongg
2
7
24
2,301
Hot off the press❗️@JAMANetwork 💪. We teamed up with #Prenuvo to study elective screening MRIs in healthy asymptomatic individuals to establish the true prevalence of pancreatic cysts. Now we know 6-7% of the population has a cyst. >21% of 80+yo. #UCSFSurgOnc #IPMN @UCSFSurgery
Among 21,651 asymptomatic adults screened with MRI, 6.3% had incidental pancreatic cystic lesions, with <1% ≥3 cm; risk increased with age, female sex, and certain medical or family histories. #PancreaticCysts #MRI
ja.ma/4lorGNs
ALT Bar graph shows prevalence of PCLs, in %. Age ranges(y) are on the x-axis and prevalence of PCLs in % is on the y-axis. The prevalence of PCLs increases with age range: \u226439 (text@1), 40-49 (text@2), 50-59 (text@3), 60-69 (text@4), 70-79 (text@5), \u226580 (text@6).
2
4
30
7,010
Packed room 4 collaborative symposium b/t @sitcancer & @SocSurgOnc on Neoadjuvant Immunotherapy #SSO2026. This approach will shape the future of many cancers we manage. Grateful to plan with @EMittendorfMD @gmboland @SDownsCanner @JohnEMullinaxMD M.Lowe,S.Cohen,G.Beasley 👏🧬
ALT Georgia Beasley, @johnemullinax, Michael Lowe, @Maker_MD, @SDownsCanner, Sonia Cohen on behalf of the SITC Surgery Committee @MDSangeetha, Simon Turcotte
5
4
27
2,520
Ajay Maker retweeted
Great meeting all the future candidates for our UCSF breast surgery fellowship program. Dr Chandler, Dr. Maker and Dr. Alvarado #SSO2026 @UCSFSurgery @Maker_MD
2
18
1,341
Congrats Profs Hirano,Noji & Takaori on fantastic IASGO Course at @HokkaidoUni Hospital & #HPB Winter Meeting 🇯🇵👏🏼. Honored to share work from #UCSFSurgicalOncology Tumor Immunology and Early Detection Lab & build new @UCSFSurgery collaborations with experts from 🇯🇵 & Europe
1
3
16
942
Ajay Maker retweeted
Consider evidence, experience and future directions of neoadjuvant IO in surgical oncology with @sitcancer experts! Join us on March 5 for a joint session at the @SocSurgOnc 2026 Annual Meeting. Learn more: ow.ly/JIBx50Y3TM6
#SSO2026 @Maker_MD @SDownsCanner
3
11
705
Ajay Maker retweeted
🧩New data coming in care of IPMN
Where are the gaps?
What studies are ongoing for monitoring, prophylaxis & stopping surveillance
🎧Explore it all with @Maker_MD @Gio_Marchegiani and Rebecca Snyder in a new episode of #SurgOncToday 🎙️
tinyurl.com/43frwavc
1
10
23
2,270
Holiday cheer with an extraordinary group. Proud of our UCSF Surgical Oncology Division and the people who make it exceptional. A wonderful evening at our annual holiday party celebrating this team that brings talent, teamwork, and heart every day🎉 #UCSFSurgOnc
2
16
1,096